Clinical Trials Browser

Phase 1/2 × darolutamide × 1 year × Clear all

NCT07190300 2026-03-02

TulmiSTAR-02

Phase 1/2 Recruiting

Bulbo-Spinal Atrophy, X-Linked

NCT03568656 2025-08-08

Study to Evaluate CCS1477 in Advanced Tumours

Phase 1/2 Completed

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06190899 2025-03-21

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Recruiting

Genital Diseases, Male, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant